Screening policy for cystic fibrosis. The role of evidence.
Wilfond
B S
BS
Department of Pediatrics, University of Arizona, Tucson, USA.
D003550:Cystic Fibrosis / Q000503:physiopathology / Q000517:prevention & control* / Q000628:therapy; D006580:Genetic Carrier Screening; D005821:Genetic Techniques; D006291:Health Policy; D006579:Heterozygote; D006801:Humans; D007231:Infant, Newborn; D008403:Mass Screening; D008962:Models, Theoretical; D017063:Outcome Assessment, Health Care; D014481:United States